Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767897 · ClinicalTrials.gov registry record
The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 72
- Enrollment target
NCT00767897 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 72 participants.
The verdict
NCT00767897 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
Interventions
- DRUG Human Papillomavirus Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-11 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00767897
The ClinicalTrials.gov registry entry for NCT00767897 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Human Papillomavirus Vaccine is the first listed.
NCT00767897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00767897 about?
NCT00767897 is a clinical study titled "The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients". The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
What is the current status of trial NCT00767897?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2011-11. Estimated completion is 2018-12.
What interventions are being tested in trial NCT00767897?
The interventions under investigation include: Human Papillomavirus Vaccine (DRUG).
Who is sponsoring clinical trial NCT00767897?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.